Carson Wealth (CWM LLC)
SYRE icon

Carson Wealth (CWM LLC)’s Spyre Therapeutics SYRE Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106K Buy
2,105
+135
+7% +$5.09K ﹤0.01% 3214
2025
Q4 		$65K Buy
1,970
+10
+0.5% +$261 ﹤0.01% 3412
2025
Q3 		$33K Buy
1,960
+248
+14% +$4.04K ﹤0.01% 3822
2025
Q2 		$26K Buy
1,712
+1,338
+358% +$19.8K ﹤0.01% 3757
2025
Q1 		$6K Buy
374
+366
+4,575% +$7.62K ﹤0.01% 4407
2024
Q4 		$0 Sell
8
-219
-96% -$6.42K ﹤0.01% 5158
2024
Q3 		$7K Buy
227
+226
+22,600% +$6.29K ﹤0.01% 3971
2024
Q2 		$0 Buy
+1
New +$34 ﹤0.01% 4928

Other funds holding SYRE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Carson Wealth (CWM LLC)'s SYRE Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Spyre Therapeutics (SYRE) stake by 6.9% in Q1 2026, buying an estimated $5.09K and bringing the position to 2,105 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #3214.

Carson Wealth (CWM LLC) first reported a position in SYRE in Q2 2024 and has held it in 8 quarters since. 197 funds tracked by Wall St. Rank hold SYRE as of Q1 2026.

  • Carson Wealth (CWM LLC) held 2,105 shares of Spyre Therapeutics worth $106K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 135 Spyre Therapeutics shares in Q1 2026, an estimated $5.09K.
  • Spyre Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3214 holding.
  • Carson Wealth (CWM LLC) first reported a position in Spyre Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 197 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.